Publications
Scientific publications
Editorials and Commentaries
Scientific Presentations
- The Lancet (June 2020): Kuderer et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- Cancer Discovery (October 2020): Rivera et al. Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study
- medRxiv preprint (February, 2021) Thompson et al. Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19.
- Annals of Oncology (March 2021) Grivas et al. Association of Clinical Factors and Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium
Scientific Presentations
Editorials and Commentaries
Scientific Presentations
- ASCO 2020 LBA110 (Warner; May 28, 2020): Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)
- ISTH 2020 Congress (Rosovsky; July 12-14, 2020) Venous Thrombotic Complications in Cancer Patients with SARS-CoV-2 Infection: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Analysis
- AACR COVID-19 and Cancer virtual meeting (Peters; July 21, 2020): Flexibility to sustain solidity: Addressing new vulnerabilities in cancer at the time of COVID-19
- AACR COVID-19 and Cancer virtual meeting (Rini; July 22, 2020): Understanding the impact of COVID in cancer patients through the COVID-19 and Cancer (CCC-19) and other COVID consortiums
- ESMO 2020 LBA71 (Wise-Draper; Sep 19, 2020): Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
- ESMO 2020 LBA72 (Grivas; Sep 20, 2020): Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
- Blood (2020) 136 (Supplement 1): 28–30: Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis
- ASH 2020 #204 (Li; Dec 5, 2020) Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
Editorials and Commentaries
Editorials and Commentaries
Editorials and Commentaries
- The Cancer Letter (Mar 20, 2020): COVID-19 and Cancer Consortium
- AACR Blog (Mar 25, 2020): COVID-19 and Cancer Consortium Forms to Collect and Share Information
- Nature Cancer (Apr 21, 2020): Crowdsourcing a crisis response for COVID19 in Oncology
- Cancer Cell (Apr 27, 2020): The COVID-19 & Cancer Consortium (CCC19): a collaborative effort to understand the effects of COVID-19 on patients with cancer
- The Cancer Letter (May 22, 2020): CCC19 bridging the knowledge gap for patients with COVID-19 and cancer
- The Cancer Letter (May 29, 2020): CCC19 data point to extensive use of hydroxychloroquine, azithromycin, or both, by patients with cancer and COVID-19
- The Lancet (May 29, 2020): Cancer and COVID-19: what do we really know?
- JCO Clinical Cancer Informatics (June 17, 2020): Crowdsourcing in Crisis: Rising to the Occasion
- Cancer Cell (Dec 14, 2020): The COVID-19 and Cancer Consortium - A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19:CCC19 Governance, Protocol, and Quality Assurance
- Advances in Radiation Oncology (October 29, 2020): The COVID-19 and Cancer Consortium (CCC19) and Opportunities for Radiation Oncology
Media
Podcasts/Interviews
Editorials and Commentaries
- OncLive (Mar 18, 2020): Cancer Registry Launches to Inform COVID19+ Patient Demographics
- Cancer Network (Mar 20, 2020): CCC19 Registry Launched to Understand COVID-19 in Patients with Cancer
- ASCO Daily News (Mar 25, 2020): The Blind Leading the Blind: COVID19, Cancer, and the Need for more data
- Urotoday (Mar 25, 2020): COVID19 and Cancer Consortium (CCC19)
- ASCO Daily News (Mar 26, 2020): Cancer Consortium Launches COVID19 Registry in Urgent Appeal for Data to Save Lives at Risk from Infection
- ASCO Post (Mar 27, 2020): The Blind Leading the Blind: COVID19, Cancer, and the Need for more data
- Medicine Matters Oncology (Mar 27, 2020): COVID-19 cancer registry launched in the USA
- Practice Update (Apr 1, 2020): Immediate Impact of COVID-19 on Cancer Care at Major Institutions.
- SWOG: The Front Line (Apr 3, 2020): COVID Registry gets its start on Twitter
- ASH Clinical News (Apr 9, 2020): COVID19, Cancer and Need for Clarity
- British Medical Journal News (Apr 17,2020): COVID19 is shattering US cancer care
- OncLive (Apr 18,2020): COVID19 and Cancer Consortium Gains International Ground
- Frontline (May 4,2020): As Pandemic claims non-COVID patients, some face difficult decisions
- Cancer Therapy Advisor (May 7, 2020) : Researchers Turn to Crowdsourcing To Learn More About COVID19 and Cancer
- Associated Press (May 28, 2020): Cancer, coronavirus are a dangerous mix, new studies find
- Cancer Network (May 28,2020): Cancer Progression Linked to Increased Risk of Death within 30 days of COVID19 diagnosis
- CNN (May 28, 2020): How having cancer can put Covid-19 patients at higher risk of dying
- MedPageToday (May 28, 2020): HCQ Linked to Harm in Cancer Patients
- Reuters Health News (May 28, 2020): Hydroxychloroquine combination risky for cancer patients with COVID19
- USA Today (May 28,2020): New study shows more cancer patients die from COVID19, but not necessarily for the reasons you'd expect
- Wall Street Journal (May 28, 2020): Higher Death Rates Found Among Cancer Patients with COVID19
- Medscape (May 29, 2020): Active Cancer Increases Death Risk in Patients With COVID-19
- The Financial Express (May 30, 2020): Death Risk higher in cancer patients
- healthline (June 9, 2020): People with Cancer Have to Choose Between Treatment and COVID-19 Risks
- ASCO Post (June 12, 2020): Factors Associated With All-Cause 30-Day Mortality in Patients With Cancer Infected With COVID-19: CCC19 Database Analysis
- Medscape (June 17, 2020): From a Tweet to the Lancet in 10 Weeks: COVID-Cancer Consortium
- ASCO Post (June 24, 2020): Results of a COVID19 and Cancer Consortium (CCC19) Cohort Study
- ASCO Post (June 25, 2020): COVID19 and Patients with Cancer: A Call to Action for Trainees
- Medscape (July 27, 2020): CCC19, Other Registries Help Define COVID-19/Cancer Landscape
- Elemental by Medium (August 5, 2020): The Unique Devastation of Cancer in a Pandemic
- Healio (August 5, 2020): Hydroxychloroquine regimens for COVID-19 linked to mortality risk for patients with cancer
- Cancer Therapy Advisor (August 12, 2020): The Twitter Effect on How Oncologists Conduct and Share Research
- VUMC Reporter (Feb. 5, 2021): Convalescent plasma improved survival in COVID-19 patients with blood cancers
- The Cancer Letter (March 19, 2021) The COVID-19 and Cancer Consortium - A year into building a United Front against the SARS-CoV-2 pandemic
- UroToday (March 22, 2021): COVID-19 and Cancer Consortium Study Highlights Increased Mortality and Racial Disparities for Patients with Cancer Diagnosed with SARS-CoV-2 Infection
Podcasts/Interviews
Podcasts/Interviews
Podcasts/Interviews
- ASCO Daily News (Mar 27, 2020): COVID19: How to Care for Patients With Cancer In a Global Pandemic
- OncLive (Mar 30, 2020): Collaborative efforts lead to launch of COVID19 and Cancer Consortium registry
- The Video Journal of Oncology (May 30, 2020): CCC19: COVID-19 and cancer
- Practice Update (Mar 30, 2020): COVID19 registry for cancer patients: Rationale
- IDSA COVID 19 Podcast (Apr 1, 2020): COVID19: What's Happening Now?
- VuMedi (Apr 1, 2020): COVID-19 Pandemic: Preparation Protocols, Telemedicine and Modifying Treatment for Cancer Patients
- eCancer (Apr 9, 2020): How COVID19 is impacting cancer patient care and clinical research
- VuMedi (Apr 17, 2020): What is the COVID19 Cancer Consortium? Urgent need to generate knowledge on COVID19
- OncLive (Apr 20, 2020): Dr. Choueiri on COVID19 and Cancer Consortium
- eCancer (May 13, 2020): The COVID19 and Cancer Consortium
- Uromigos (May 29, 2020): Episode 27: COVID-19 in > 1000 Cancer Patients with Jeremy Warner (CCC-19)
- CancerNetwork (May 29, 2020): Petros Grivas, MD, PhD, on the Future of the CCC19 Registry
- VJOncology (May 30, 2020): CCC19: COVID-19 and cancer
- ecancer (31 May, 2020): Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)
- Medicine Matters oncology (1 June, 2020): Initial data from CCC19
- CancerNetwork (July 28, 2020): Jeremy L. Warner, MD, MS, on Updated Findings from the COVID-19 and Cancer Consortium
- OnLive (August 14, 2020): Dr. Choueiri on the Significance of the CCC19 During the COVID-19 Crisis
- Oncology Learning Network (Aug 18, 2020): Dr Lyman and Dr Desai Talk COVID-19, Cancer Care, and the CCC19 Initiative
- OBRoncology (Sep 24, 2020): Petros Grivas, MD, PhD, discusses the COVID-19 and Cancer Consortium (CCC19) from ESMO 2020
- VJOncology (Oct 2, 2020): CCC19: assessment of clinical and laboratory prognostic factors
- VJOncology (Oct 5, 2020): CCC19: systemic cancer treatment-related outcomes
- Onconews (March, 2021): COVID-19 and Cancer: A year later, What do we know?
Copyright © 2020 CCC19 - All Rights Reserved.
Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.
Powered by GoDaddy Website Builder
Cookie Policy
This website uses cookies. By continuing to use this site, you accept our use of cookies.